The backcalculation method has been extensively used in AIDS modelling and forecasting. Knowledge of reported AIDS cases, information on the time between HIV infection and onset of AIDS, and assumptions on the rate at which infections occurs, can be used to reconstruct the past history of the HIV epidemic, as well as to provide short term predictions of AIDS incidence. Uncertainty in the three components of the backcalculation method and the increasingly available information on HIV prevalence must be taken into account in order to provide realistic projections. In this paper we discuss ways of acknowledging uncertainty and suggest a Bayesian formulation of the backcalculation idea as a means of combining into a single model both random and systematic variation as well as prior information.
Get full access to this article
View all access options for this article.
References
1.
Waight PA, Rush AM, Miller E.Surveillance of HIV infection by voluntary testing in England. Communicable Disease Report1992; 2: R85-90.
2.
Goldberg DJ, Emslie JA, Smyth W., Reid D.A system for surveillance of voluntary HIV testing: results of the first 2 years; 1989-1990. AIDS1992; 6: 495-500.
3.
Gill ON, Adler MW, Day NEMonitoring the prevalence of HIV. Foundation for a programme of unlinked anonymous testing in England and Wales. British Medical Journal1989; 299: 1295-98.
4.
PHLS AIDS Centre, PHLS Virus Reference Laboratory, Academic Department of Genitourinary Medicine University College and Middlesex School of Medicine and Collaborators.The unlinked anonymous HIV prevalence monitoring programme in England and Wales: preliminary results . Communicable Disease Report1991; 1: R69-76.
5.
Bird AG, Gore SM, Jolliffe DW, Burns SMAnonymous HIV surveillance in Saughton Prison, Ediburgh. AIDS1992; 6: 725-33.
6.
CD4 Collaborative Group.Use of monitored CD4 cell counts: predictions of the AIDS epidemic in Scotland . AIDS1992; 6: 213-22.
7.
Hoover DR, Graham Nmh, Chen B., Taylor Jmg, Phair J., Zhou Sys, Munõz A.Effects of CD4+ cell count measurement variability on staging HIV-1 infection . Journal of AIDS1992; 5:794-802.
8.
Report of a Working Group(Chairman: Dr DB McClelland) convened by the Chief Medical Officer, Scottish Home and Health Development. Acquired immune deficiency syndrome in Scotland. Projections to the end of 1993. Edinburgh: HMSO, 1990 .
9.
Satten, GA, Longini IM Jr.Estimation of incidence of HIV infection using cross-sectional marker surveys . Biometrics1992 (in press).
10.
Brookmeyer R., Gail MHA method for obtaining short term projections and lower bounds on the size of the AIDS epidemic. Journal of the American Statistical Association1988;83:301-08.
11.
Wastila LJ, Lasagna L.The history of Zidovudine (AZT). Journal of Clinical Research and Pharmacoepidemiology1990; 4: 25-37.
12.
Taylor Jmg.Models for the HIV infection and AIDS epidemic in the United States . Statistics in Medicine1989; 8: 45-58.
13.
Rosenberg PS , Gail MHUncertainty in estimates of HIV prevalence derived by backcalculation. Annals of Epidemiology1990; 1: 105-15.
14.
Rosenberg PS , Biggar RJ, Goerdert JJ, Gail MHBackcalculation of the number with human immunodeficiency virus infection in the United States . American Journal of Epidemiology1991; 133: 276-85.
15.
Brookmeyer R.Reconstruction and future trends of AIDS epidemic in the United States. Science1991; 253: 37-42.
16.
Cox DR, Medley GFA process of events with notification delay and the forecasting of AIDS. Philosophical Transactions, Royal Society of London B 1989; 325: 135-45.
17.
Heisterkamp SH, Jager JC, Ruitenberg EJ, Van Druten Jam, Downs AMCorrecting reported AIDS incidence: a statistical approach. Statistics in Medicine1989; 8: 963-76.
18.
Lawless J., Sun J.A comprehensive backcalculation framework for estimation and prediction of AIDS cases. In: Jewell N, Dietz K, Farewell, V eds. AIDS epidemiology: methodological issues. Boston: Birkhäuser-Boston, 1992.
19.
Brookmeyer R., Damiano A.Statistical methods for short-term projections of AIDS incidence. Statistics in Medicine1990; 8: 23-34.
20.
Zeger SL, See LC, Diggle PJStatistical methods for monitoring the AIDS epidemic. Statistics in Medicine1989; 8: 3-21.
21.
Rosenberg P.A simple correction of AIDS surveillance data for reporting delays. Journal of AIDS1990 ; 3: 49-54.
22.
Brookmeyer R., Liao J.Statistical modelling of the AIDS epidemic for forecasting health care needs. Biometrics1990; 46: 1151-63.
23.
Harris JEReporting delays and the incidence of AIDS. Journal of the American Statistical Association1990; 85: 915-24.
24.
Kalbfleisch JD, Lawless JFInference based on retrospective ascertainment: an analysis of data on transfusion related AIDS. Journal of the American Statistical Association1989; 84: 360-72.
25.
De Angelis D. , Gilks WREstimating AIDS incidence taking account of reporting delays (in preparation).
26.
Efron B.The jackknife, the bootstrap and other resampling plans. Philadelphia: SIAM, 1982.
27.
Geman S., Geman D.Stochastic relaxation, Gibbs distributions and the Bayesian restoration of images. IEEE Transactions on Pattern Analysis and Machine Intelligence1984; 6: 721-41.
28.
Gelfand AE, Smith Afm.Sampling-based approaches to calculating marginal densities. Journal of the American Statistical Association1990 ;85:398-409.
29.
Medley GF, Anderson RM, Cox DR, Billard L.Incubation period of AIDS in patients infected via blood transfusion . Nature1987; 328: 719-21.
30.
Hendriks Jcm , Medley GF, van Druten Jam.The treatment free incubation period of AIDS in a cohort of homosexual men. AIDS1992 (in press).
31.
Rutherford GW, Lifson AR, Hessol NA et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. British Medical Journal1990; 301:1183-88.
32.
Brookmeyer R., Gail MH, Polk BFThe prevalent cohort study and the acquired immunodeficiency syndrome. American Journal of Epidemiology1987; 126: 14-24.
33.
Simmonds P. , Beatson D., Cuthbot Rjg, Watson H. et al. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia HIV cohort. Lancet1991; 338: 1159-63.
34.
McNeil A.Statistical methods in AIDS progression studies with an analysis of the Edinburgh City Hospital Cohort [PhD Thesis]. Cambridge : University of Cambridge, 1993 .
35.
Learmont J. , Tindall B., Evans L. et al. Long-term symptoless HIV-1 infection in recipients of blood products from single donors. Lancet1992; 340: 863-67.
36.
Raab G., Gore SM et al. Forecasting the AIDS epidemic in Scotland (in preparation).
37.
Abedort NW, Higartner MN, Pike MC, Gjerset GF et al. Variability in serial CD4 counts and relation to progression of HIV-1 infection to AIDS in haemophiliac patients. British Medical Journal1992; 304: 212-16.
38.
Braxhult A. , Granath F. et al. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion . AIDS1990; 4: 125-29.
39.
Eyster ME, Gail MH et al. Natural history of human immunodeficiency virus infections in haemophiliacs: effects of T-cell subsets, platelet counts, and age. Annals of Internal Medicine1987; 107: 1-6.
40.
Phillips AN , Lee CA et al. More rapid progression to AIDS in older infected people: the role of CD4+ T-cell counts. Journal of AIDS1991; 4: 970-75.
41.
Moss AR, Bacchetti P. et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow up of the San Francisco General Hospital cohort . British Medical Journal1988; 296: 745-50.
42.
Fischl MA, Richman DD, Grieco MH et al. The efficacy of zidovudine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine1987; 317: 185-91.
43.
Volberding PA, Lagakos SW et al. Zidovudine in asymptomatic human immunodeficiency cirus infection. New England Journal of Medicine1990; 322: 941-49.
44.
Graham Nhm, Zeger SL, Park LP et al. Effects of zidovudine and pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. Lancet1991; 338: 265-69.
45.
Dalgleish AG , Wilson S., Gompels M. et al. T-cell receptor variable gene products and early HIV-1 infection. Lancet1992; 339: 824-28.
46.
Brookmeyer R., Liao J.The analysis of delays in disease reporting: methods and results for the acquired immunodeficiency syndrome . American Journal of Epidemiology1990 ; 132: 355-65.
47.
Gail MH, Rosenberg PSPerspectives on using backcalculation to estimates of HIV prevalence and project AIDS incidence. In: Jewell N, Dietz K, Farewell V eds. AIDS Epidemiology: Methodological Issues. Boston: Birkhäuser-Boston, 1992.
48.
Gill ON, Evans BG, Porter K. et al. Revised indirect estimates of the total number of HIV-1 infected persons in England and Wales. Abstract PoC 4456. In: VIII International Conference onAIDS/III STD World Congress. Amsterdam, The Netherlands, 19-24 July 1992.
49.
Lange N., Carlin BP, Gelfand AEHierarchical Bayes models for the progression of HIV infection using longitudinal CD4+ counts. Journal of the American Statistical Association1992 (in press).
50.
Gilks WR, Clayton DG, Spiegelhalter DJ et al. Modelling complexity: applications of Gibbs sampling in medicine . Journal of the Royal Statistical Society B1992 (in press).
51.
Gilks WR, Richardson S.Analysis of disease risks using ancillarity risk factors, with application to job-exposure matrices. Statistics in Medicine1992; 2: 1443-63.
